Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells

BACKGROUND: Some cytokine signaling pathways can interact with interferon (IFN)-α pathway and thus regulate cell responses to IFN-α. Levels of the pro-inflammatory cytokine interleukin-17A (IL-17A) were found to be elevated in both the peripheral blood and liver in chronic hepatitis B (CHB) patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiaxuan, Liu, Kai, Zhang, Gaoli, Ling, Ning, Chen, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830041/
https://www.ncbi.nlm.nih.gov/pubmed/35144643
http://dx.doi.org/10.1186/s12985-022-01753-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830041/
https://www.ncbi.nlm.nih.gov/pubmed/35144643
http://dx.doi.org/10.1186/s12985-022-01753-x

Ejemplares similares